U.S. markets open in 5 hours 36 minutes
  • S&P Futures

    4,537.25
    -4.50 (-0.10%)
     
  • Dow Futures

    35,482.00
    +2.00 (+0.01%)
     
  • Nasdaq Futures

    15,417.50
    -61.25 (-0.40%)
     
  • Russell 2000 Futures

    2,297.50
    +3.40 (+0.15%)
     
  • Crude Oil

    82.45
    -0.05 (-0.06%)
     
  • Gold

    1,792.70
    +10.80 (+0.61%)
     
  • Silver

    24.39
    +0.22 (+0.89%)
     
  • EUR/USD

    1.1644
    +0.0014 (+0.12%)
     
  • 10-Yr Bond

    1.6760
    0.0000 (0.00%)
     
  • Vix

    15.24
    -0.25 (-1.61%)
     
  • GBP/USD

    1.3784
    -0.0012 (-0.08%)
     
  • USD/JPY

    113.9080
    -0.0800 (-0.07%)
     
  • BTC-USD

    63,221.74
    -1,839.90 (-2.83%)
     
  • CMC Crypto 200

    1,503.82
    -30.83 (-2.01%)
     
  • FTSE 100

    7,217.36
    +27.06 (+0.38%)
     
  • Nikkei 225

    28,804.85
    +96.27 (+0.34%)
     

Those who invested in IDEXX Laboratories (NASDAQ:IDXX) five years ago are up 513%

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

For many, the main point of investing in the stock market is to achieve spectacular returns. And highest quality companies can see their share prices grow by huge amounts. Just think about the savvy investors who held IDEXX Laboratories, Inc. (NASDAQ:IDXX) shares for the last five years, while they gained 513%. If that doesn't get you thinking about long term investing, we don't know what will. On top of that, the share price is up 28% in about a quarter. The company reported its financial results recently; you can catch up on the latest numbers by reading our company report. It really delights us to see such great share price performance for investors.

So let's investigate and see if the longer term performance of the company has been in line with the underlying business' progress.

See our latest analysis for IDEXX Laboratories

In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

During five years of share price growth, IDEXX Laboratories achieved compound earnings per share (EPS) growth of 31% per year. This EPS growth is lower than the 44% average annual increase in the share price. This suggests that market participants hold the company in higher regard, these days. And that's hardly shocking given the track record of growth. This favorable sentiment is reflected in its (fairly optimistic) P/E ratio of 79.58.

The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image).

earnings-per-share-growth
earnings-per-share-growth

We know that IDEXX Laboratories has improved its bottom line over the last three years, but what does the future have in store? You can see how its balance sheet has strengthened (or weakened) over time in this free interactive graphic.

A Different Perspective

We're pleased to report that IDEXX Laboratories shareholders have received a total shareholder return of 75% over one year. That gain is better than the annual TSR over five years, which is 44%. Therefore it seems like sentiment around the company has been positive lately. In the best case scenario, this may hint at some real business momentum, implying that now could be a great time to delve deeper. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. To that end, you should be aware of the 2 warning signs we've spotted with IDEXX Laboratories .

We will like IDEXX Laboratories better if we see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.